Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AL1TER™: Alpha-1 Therapy, Evaluation, and Research Patient Registry

NCT01974830 is registered in ClinicalTrials.gov with Coram Clinical Trials as lead sponsor.

NCT NCT01974830
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01974830 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AL1TER™: Alpha-1 Therapy, Evaluation, and Research Patient Registry
Lead sponsor
Coram Clinical Trials
Phase
Observational
Overall status
Completed
Start date
October 31, 2013
Completion date
September 6, 2019
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alpha-1 anti-trypsin deficiency